Novogene Co., Ltd. (688315.SS)
CNY 14.01
(0.57%)
CNY 14.01
(0.57%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.12 Billion CNY | 4.48% |
| 2022 | 1.07 Billion CNY | 1.01% |
| 2021 | 1.06 Billion CNY | 17.48% |
| 2020 | 903.85 Million CNY | 2.34% |
| 2019 | 883.16 Million CNY | 76.91% |
| 2018 | 499.21 Million CNY | 2.31% |
| 2017 | 487.92 Million CNY | 12.53% |
| 2016 | 433.59 Million CNY | -1.36% |
| 2015 | 439.56 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 985.87 Million CNY | -2.61% |
| 2024 Q3 | 1.03 Billion CNY | 4.59% |
| 2024 Q1 | 1.01 Billion CNY | -9.66% |
| 2023 Q4 | 1.12 Billion CNY | 22.01% |
| 2023 FY | 1.12 Billion CNY | 4.48% |
| 2023 Q1 | 1.08 Billion CNY | 0.94% |
| 2023 Q2 | 1.05 Billion CNY | -2.11% |
| 2023 Q3 | 918.45 Million CNY | -13.34% |
| 2022 Q4 | 1.07 Billion CNY | 8.16% |
| 2022 FY | 1.07 Billion CNY | 1.01% |
| 2022 Q3 | 991.63 Million CNY | -0.95% |
| 2022 Q2 | 1 Billion CNY | 7.7% |
| 2022 Q1 | 929.56 Million CNY | -12.46% |
| 2021 Q3 | 815.3 Million CNY | -0.73% |
| 2021 FY | 1.06 Billion CNY | 17.48% |
| 2021 Q1 | 850.79 Million CNY | -5.87% |
| 2021 Q2 | 821.25 Million CNY | -3.47% |
| 2021 Q4 | 1.06 Billion CNY | 30.24% |
| 2020 FY | 903.85 Million CNY | 2.34% |
| 2020 Q4 | 903.85 Million CNY | 2.5% |
| 2020 Q3 | 881.8 Million CNY | -0.22% |
| 2020 Q2 | 883.75 Million CNY | 4.62% |
| 2020 Q1 | 844.73 Million CNY | -4.35% |
| 2019 FY | 883.16 Million CNY | 76.91% |
| 2019 Q2 | 596.03 Million CNY | 2.06% |
| 2019 Q3 | 872.89 Million CNY | 46.45% |
| 2019 Q4 | 883.16 Million CNY | 1.18% |
| 2019 Q1 | 584.01 Million CNY | 16.99% |
| 2018 Q2 | 426.5 Million CNY | 3.56% |
| 2018 Q3 | 486.96 Million CNY | 14.17% |
| 2018 Q4 | 499.21 Million CNY | 2.52% |
| 2018 FY | 499.21 Million CNY | 2.31% |
| 2018 Q1 | 411.84 Million CNY | 0.0% |
| 2017 FY | 487.92 Million CNY | 12.53% |
| 2016 FY | 433.59 Million CNY | -1.36% |
| 2015 FY | 439.56 Million CNY | 0.0% |